Invention Grant
US07816370B2 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
有权
使用埃坡霉素治疗神经元连通性缺陷如精神分裂症和自闭症
- Patent Title: Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
- Patent Title (中): 使用埃坡霉素治疗神经元连通性缺陷如精神分裂症和自闭症
-
Application No.: US10586486Application Date: 2005-01-28
-
Publication No.: US07816370B2Publication Date: 2010-10-19
- Inventor: Annie Andrieux , Didier Job , Annie Schweitzer , Gerhard Höfle
- Applicant: Annie Andrieux , Didier Job , Annie Schweitzer , Gerhard Höfle
- Applicant Address: FR Paris FR Paris DE Braunschweig
- Assignee: Institut National de la Sante et de la Recherche Medicale,Commissariat a l'Energie Atomique,Helmhaltz Zentrum Fur Infektions Forschung GmbH
- Current Assignee: Institut National de la Sante et de la Recherche Medicale,Commissariat a l'Energie Atomique,Helmhaltz Zentrum Fur Infektions Forschung GmbH
- Current Assignee Address: FR Paris FR Paris DE Braunschweig
- Agency: Oliff & Berridge, PLC
- Priority: EP04290249 20040130
- International Application: PCT/IB2005/000217 WO 20050128
- International Announcement: WO2005/075023 WO 20050818
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A61K31/44

Abstract:
The present invention is about the use of at least one epothilone or derivative thereof as an active ingredient for manufacturing a medicament for use in the treatment of disease(s) involving a neuronal connectivity defect, such as schizophrenia or autism.
Public/Granted literature
- US20080207697A1 Use of Epothilones in the Treatment of Neuronal Connectivity Defects Such as Schizophrenia and Autism Public/Granted day:2008-08-28
Information query
IPC分类: